These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A brief history of neurological botulinum toxin therapy in Germany. Dressler D; Roggenkaemper P J Neural Transm (Vienna); 2017 Oct; 124(10):1217-1221. PubMed ID: 28733711 [TBL] [Abstract][Full Text] [Related]
6. Therapeutically relevant features of botulinum toxin drugs. Dressler D Toxicon; 2020 Feb; 175():64-68. PubMed ID: 32056697 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for treatment of dystonia. Dressler D Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacology of botulinum toxin drugs]. Dressler D HNO; 2012 Jun; 60(6):496-502. PubMed ID: 22669438 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin therapy: reduction of injection site pain by pH normalisation. Dressler D; Adib Saberi F; Bigalke H J Neural Transm (Vienna); 2016 May; 123(5):527-31. PubMed ID: 27002815 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure. Dressler D; Bigalke H J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin: from poison to pharmaceutical. The history of a poison that became useful to mankind. Kreyden OP Curr Probl Dermatol; 2002; 30():94-100. PubMed ID: 12471702 [No Abstract] [Full Text] [Related]
12. [Current outlook on botulinum toxin medications]. Dressler D Nervenarzt; 2007 Dec; 78(12):1444-6. PubMed ID: 18008058 [TBL] [Abstract][Full Text] [Related]
13. Clinical use of non-A botulinum toxins: botulinum toxin type B. Dressler D; Eleopra R Neurotox Res; 2006 Apr; 9(2-3):121-5. PubMed ID: 16785108 [TBL] [Abstract][Full Text] [Related]
14. Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins. Dressler D Eur J Neurol; 2012 Mar; 19(3):385-9. PubMed ID: 22035051 [TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin: from drug to poison]. Dressler D; Saberi FA Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S49-54. PubMed ID: 19685394 [TBL] [Abstract][Full Text] [Related]
16. History of the clinical use of botulinum toxin A and B. Carruthers A Clin Dermatol; 2003; 21(6):469-72. PubMed ID: 14759577 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin: State of the art. Jankovic J Mov Disord; 2017 Aug; 32(8):1131-1138. PubMed ID: 28639368 [TBL] [Abstract][Full Text] [Related]